Bachelor's degree Biomedical Sciences


Academic profile: Doctorate


Teaching Course Subject
Degree in Biotechnology 1 CELLULAR BIOLOGY
Degree in Biomedical Sciences 1 CELLULAR BIOLOGY


Research profile: Developmental and oncogenic signalling
Thesis Year Direction
Co-directora de tesis: Utilitat de la immunohistoquímica i els tissue micro arrays en el coneixament de les alteracions moleculars del càncer d'endometri 2015 Matias Guiu, Xavier; Yeramian, Andree
Publications Year Authors Type
Oxidative-stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness. 2023 Lopez Mejia. I.C.; Pijuan, J.; Navaridas, R.; Santacana, M.; Gatius, S.; Velasco, A.; Castellà, G.; Panosa, A.; Cabiscol, E.; Pinyol, M.; Coll, L.; Bonifaci, N.; Plata Peña, L.; Vidal, A.; Villanueva, Article d'investigació
Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition 2022 Ruiz Mitjana, A.; Navaridas, R.; Vidal Sabanés, M.; Perramon Güell, A.; Yeramian, A.; Felip, I.; Eritja, N.; Egea, J.; Encinas, M.; Matias Guiu, X.; Dolcet, X. Article d'investigació
A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes. 2022 Altés, G.; Vaquero, M.; Cuesta, S.; Anerillas, C.; Macià, A.; Espinet, C.; Ribera, J.; Bellusci, S.; Klein, O.D.; Yeramian, A.; Dolcet, X.; Egea, J.; Encinas, M. Article d'investigació
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer 2022 Gatius, S.; Jove, M.; Megino Luque, C.; Albertí Valls, M.; Yeramian, A.; Bonifaci, N.; Piñol, M.; Santacana, M.; Pradas, I.; Llobet Navas, D.; Pamplona, R.; Matías Guiu, X.; Eritja, N. Article d'investigació
Randomized clinical trial to evaluate the morphological changes in the adventitial vasa vasorum density and biological markers of endothelial dysfunction in subjects with moderate obesity undergoing a 2021 Sánchez, E.; Santos, M.D.; Nuñez Garcia, M.; Bueno, M.; Sajoux, I.; Yeramian, A.; Lecube, A. Article d'investigació
Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes. 2019 López Cano, C.; Gutiérrez Carrasquilla, L.; Sánchez, E.; González, J.; Yeramian, A.; Martí, R.; Hernández, M.; Cao, G.; Ribelles, M.; Gómez, X.; Barril, S.; Barbé, F.; Hernández, C.; Simó, R.; Lecube Article d'investigació
Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS project. 2019 Sánchez, E.; Lecube, A.; Betriu, A.; Hernández, C.; López Cano, C.; Gutiérrez Carrasquilla, L.; Kerkeni, M.; Yeramian, A.; Purroy, F.; Pamplona, R.; Farràs, C.; Fernández, E.; Barbé, F.; Simó, R. Article d'investigació
Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project. 2019 Sánchez, E.; Betriu, À.; Yeramian, A.; Fernández, E.; Purroy, F.; Sánchez de la Torre, M.; Pamplona, R.; Miquel, E.; Kerkeni, M.; Hernández, C.; Simó, R.; Lecube, A.; Hernández, M.; Rius, F.; Polanco, Article d'investigació
The influence of sleep apnea syndrome and intermittent hypoxia in carotid adventitial vasa vasorum. 2019 López Cano, C.; Rius, F.; Sánchez, E.; Gaeta, AM.; Betriu, À.; Fernández, E.; Yeramian, A.; Hernández, M.; Bueno, M.; Gutiérrez Carrasquilla, L.; Dalmases, M.; Lecube, A. Article d'investigació
Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers. 2018 Nager M, Sallán MC, Visa A, Pushparaj C, Santacana M, Macià A, Yeramian A, Cantí C & Herreros J. Article d'investigació
Influence of Morbid Obesity and Bariatric Surgery Impact on the Carotid Adventitial Vasa Vasorum Signal 2018 Rius, F.; Sánchez, E.; Betriu, À.; Baena Fustegueras, J.A.; Yeramian, A.; Vidal, T.; Hernández, M.; López Cano, C.; Bueno, M.; Gutiérrez Carrasquilla, L.; Herrerías, F.; de la Fuente, M.C.; Fernández, Article d'investigació
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer 2017 Eritja N; Chen BJ; Rodríguez-Barrueco R; Santacana M; Gatius S; Vidal A; Martí MD; Ponce J; Bergadà L; Yeramian A; Encinas M; Ribera J; Reventós J; Boyd J; Villanueva A; Matias-Guiu X; Dolcet X; Llobe Article d'investigació
Endometrial Carcinoma: Specific Targeted Pathways. 2017 Eritja N; Yeramian A; Chen BJ; Llobet-Navas D; Ortega E; Colas E; Abal M; Dolcet X; Reventos J; Matias-Guiu X. Review
A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium. 2017 Eritja, N.; Felip, I.; Dosil, M.A.; Vigezzi, L.; Mirantes, C.; Yeramian, A.; Navaridas, R.; Santacana, M.; Llobet Navas, D.; Yoshimura, A.; Nomura, M.; Encinas, M.; Matias Guiu, X.; Dolcet, X. Article d'investigació
Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer 2016 Yeramian, A.; García, V.; Bergadà, L.; Domingo, M.; Santacana, M.; Valls, J.; Martinez Alonso, M.; Carceller, J.A.; Cussac, A.L.; Dolcet, X.; Matias Guiu, X. Article en premsa
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism 2016 Jove M; Gatius S; Yeramian A; Portero-Otin M; Eritja N; Santacana M; Ruiz M; Pamplona R; Matias-Guiu X. Article d'investigació
2-phenylethynesulfonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels 2016 Yeramian, A.; Vea, A.; Benítez, S.; Ribera, J.; Domingo, M.; Santacana, M.; Martinez, M.; Maiques, O.; Valls, J.; Dolcet, X.; Vilella, R.; Cabiscol, E.; Matias Guiu, X.; Marti, R.M. Article d'investigació
Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition 2016 Jonsson, M.; Ragnum, HB.; Julin, C.H.; Yeramian, A.; Clancy, T.; Frikstad, K.M.; Seierstad, T.; Stokke, T.; Matias Guiu, X.; Ree, A.H.; Flatmark, K.; Lyng, H. Article d'investigació
Antioxidants impair anti-tumoral effects of vorinostat, but not anti-neoplastic effects of vorinostat and caspase-8 downregulation 2014 Bergadà L; Yeramian A; Sorolla A; Matias-Guiu X; Dolcet X. Article d'investigació
Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells 2013 Bergadà, L.; Sorolla, A.; Yeramian, A.; Eritja, N.; Mirantes, C.; Matias Guiu, X.; Dolcet, X. Article d'investigació
Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometriaT cells and drives PTEN loss-induced hyperplasic growth 2013 Eritja, N.; Mirantes, C.; Llobet, D.; Yeramian, A.; Bergadà, L.; Dosil, M.A.; Domingo, M.; Matias Guiu, X.; Dolcet, X. Article d'investigació
Arginine transport is impaired in C57Bl/6 mouse macrophages as a result of a deletion in the promoter of Slc7a2 (CAT2), and susceptibility to Leishmania infection is reduced 2013 Sans-Fons MG; Yeramian A; Pereira-Lopes S; Santamaría-Babi LF; Modolell M; Lloberas J; Celada A. Article d'investigació
New therapeutic targets in melanoma 2012 Martí, R.M.; Sorolla, A.; Yeramian, A. Review
Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells 2012 Sorolla, A.; Yeramian, A.; Valls, J.; Dolcet, X.; Bergadà, L.; Llombart, Cussac, A.; Martí, R.M.; Matias Guiu, X. Article d'investigació
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway 2012 Yeramian, A.; Sorolla, A.; Dolcet, X.; Velasco, A.; Santacana, M.; Valls, J.; Abal, L.; Moreno, S.; Egido, R.; Casanova, J.M.; Puig, S.; Vilella, R.; Llombart Cussac, A.; Matias Guiu, X.; Marti, R.M. Article d'investigació
Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia. 2012 Santacana, M.; Yeramian, A.; Velasco, A.; Bergada, L.; Gatius, S.; García, V.; Azueta, A.; Palacios, J.; Dolcet, X.; Oliva, E.; Matias Guiu, X. Article d'investigació
Endometrial carcinoma: molecular alterations involved in tumor development and progression. 2012 Yeramian A; Moreno-Bueno G; Dolcet X; Catasus L; Abal M; Colas E; Reventos J; Palacios J; Prat J; Matias-Guiu X. Article d'investigació
Arginine and macrophage activation 2012 Comalada M; Yeramian A; Modolell M; Lloberas J; Celada A. Article d'investigació
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. 2011 Llobet, D.; Eritja, N.; Domingo, M.; Bergada, L.; Mirantes, C.; Santacana, M.; Pallares, J.; Macià, A.; Yeramian, A.; Encinas, M.; Moreno Bueno, G.; Palacios, J.; Lewis, R.E.; Matias Guiu, X.; Dolcet, Article d'investigació
Nuclear factor-kappa B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1 alpha independent manner 2011 Yeramian, A.; Santacana, M.; Sorolla, A.; Llobet, D.; Encinas, M.; Velasco, A.; Bahi, N.; Eritja, N.; Domingo, M.; Oliva, E.; Dolcet, X.; Matias Guiu, X. Article d'investigació
The multikinase inhibitor sorafenib induces apoptosis and sensitizes endometrial cancer cells to TRAIL by different mechanisms 2010 Llobet, D.; Eritja, N.; Encinas, M.; Yeramian, A.; Pallares, J.; Sorolla, A.; Santacana, M.; Gonzalez Tallada, F.J.; Matias Guiu, X.; Dolcet, X. Article d'investigació
A novel 3D culture system of polarized epithelial cells to study endometrial carcinogenesis 2010 Eritja N; Llobet D; Domingo M; Yeramian A; Matias-Guiu X; Dolcet X. Article d'investigació
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma 2010 Velasco A; Pallares J; Santacana M; Gatius S; Fernandez M; Domingo M; Valls J; Yeramian A; Encinas M; Dolcet X; Matias-Guiu X. Article d'investigació
Molecular pathology of endometrial carcinoma; practical aspects from the diagnostic and therapeutical view points 2009 Llobet D; Pallares J; Yeramian A; Santacana M; Eritja N; Velasco A; Dolcet X; Matias-Guiu X Review
A review of the aplications of tissue microarray technology in understanding the molecular features of endometrial carcinoma 2009 Pallarés J; Santacana M; Puente S; López S; Yeramian A; Eritja N; Sorolla A; Llobet D; Dolcet X; Matias-Guiu X Review
Expression of somatostatin receptors in human melanoma cell lines: Effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation 2009 Martinez-Alonso M; Llecha N; Mayorga ME; Sorolla A; Dolcet X; Sanmartin V; Abal L; Casanova JM; Baradad M; Yeramian A; Egido R; Puig S; Vilella R; Matias-Guiu X; Marti RM Article d'investigació
CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation. 2009 Pallares J; Llobet D; Santacana M; Eritja N; Velasco A; Cuevas D; Lopez S; Palomar-Asenjo V; Yeramian A; Dolcet X; Matias-Guiu X. Article d'investigació
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells 2008 Llobet D; Eritja N; Encinas M; Sorolla A; Yeramian A; Schoenenberger JA; Llombart-Cussac A; Martí RM; Matias-Guiu X; Dolcet X Article d'investigació
Deacetylase activity is required for STAT-5 dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. 2008 Sebastián C; Serra M; Yeramian A; Serrat N; Lloberas J; Celada A. Article d'investigació
Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines 2008 Sorolla A; Yeramian A; Dolcet X; Pérez de Santos AM; Llobet D; Schoenenberger JA; Casanova JM; Soria X; Egido R; Llombart A; Vilella R; Matias-Guiu X; Marti RM. Article d'investigació
Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential beta-catenin phosphorylation 2008 David, M.D.; Yeramian, A.; Duñach, M.; Llovera, M.; Cantí, C.; García de Herreros, A.; Comella, J.X.; Herreros, J. Article d'investigació
Targeted therapies in gynecologic cancers and melanoma 2008 Ortega E; Marti RM; Yeramian A; Sorolla A; Dolcet X; Llobet D; Abal L;Santacana M; Pallares J; Llombart-Cussac A; Matias-Guiu X Review
Loss of heterozygosity in endometrial carcinoma 2008 Velasco A; Pallarés J; Santacana M; Yeramian A; Dolcet X; Eritja N; Puente S; Sorolla A; Llecha N; Matias-Guiu X Review
Nuclear factor-kappa B activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma 2008 Gallel P; Pallares J; Dolcet X; Llobet D; Eritja N; Santacana M; Yeramian A; Palomar-Asenjo V; Lagarda H; Mauricio D; Encinas M; Matias-Guiu X Article d'investigació
CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells 2008 Llobet D; Eritja N; Encinas M; Llecha N; Yeramian A; Pallares J; Sorolla A; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X Article d'investigació
Arginine transport via cationic amino acid transporter 2 plays a critical regulatory role in classical or alternative activation of macrophages. 2006 Yeramian A; Martin L;Serrat N; Arpa L; Soler C;Bertran J; McLeod C; Palacín M; Modolell M;Lloberas J; Celada A. Article d'investigació
Macrophages require distinct arginine catabolism and transport systems for proliferation and for activation 2006 Yeramian A; Martin L; Arpa L; Bertran J; Soler C; McLeod C; Modolell M; Palacín M; Lloberas J; Celada A Article d'investigació